Odyssean »

salesforce shares owned by Odyssean

Quarter-by-quarter ownership of salesforce (CRM) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in salesforce

Tip: Access up to 7 years of quarterly data

All positions including salesforce held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in salesforce by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 18k 156.66

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding salesforce

BlackRock
Vanguard Capital Management
State Street Corporation
Morgan Stanley
Geode Capital Management
Jane Street
Capital World Investors
Susquehanna International
Harris Associates L.P
Vanguard Portfolio Management
Capital Research Global Investors
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Capital Research and Management Company - Division 3
Bank of America Corporation

View all funds holding salesforce